对于帕金森病的治疗,尽管左旋多巴初期疗效较好,但并未能解决该病长期治疗的问题。有学者报告多巴胺受体兴奋剂早期与左旋多巴结合治疗可有效地解决这一问题。为进一步阐明这一点,作者对90例帕金森病者进行了随机前瞻性研究,比较单独用麦角乙脲(多巴胺受体兴奋剂)或早期麦角乙脲与左旋多巴联用或单用左旋多巴长期治疗的效果。 For the treatment of Parkinson’s disease, although the initial effect of levodopa is better, it does not solve the long-term treatment of the disease. Some scholars report dopamine receptor agonist early combination with levodopa can effectively solve this problem. To further elucidate this point, the authors randomized 90 patients with Parkinson’s disease were prospectively studied, compared with lisuride alone (dopamine agonist) or early lisuride with levodopa combined or single-use more Pakistan long-term treatment effect.